10.09.19

Ex-Shire CEO Flemming Ornskov Emerges as Galderma CEO after $10B Nestlé Spinout

Source: FiercePharma

As Takeda folds in Shire, two of the Irish rare disease specialist’s former top leaders have found themselves a new home at Nestlé skin health spinoff Galderma, according to a report in FiercePharma.

Flemming Ornskov, Shire’s most recent CEO before the Takeda buyout, has taken the reins as Galderma CEO. And Shire’s former finance overseer, Thomas Dittrich, will work alongside him as CFO of Galderma, a company that now holds the title of the world’s largest independent dermatology-focused drugmaker.

Read the full article.

Related Content